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Abstract: Cell-based therapy is a promising strategy for promoting tissue regeneration when conventional treatments are not effective.
The choice of the accessible source to obtain a sufficient cell amount and the use of suitable biomaterials to improve the cell delivery
efficiency are the main tasks for safe, effective, and reliable application of stem cell therapy. In this study, we have compared the influence
of bone marrow-derived Lin¯ cells on skin regeneration after local transplantation with or without type I collagen-based gel in a BALB/c
mice full-thickness wound model. Lin¯ cells were isolated using magnetic-associated cell sorting and identified by flow cytometry.
Cytokine gene expression was examined using real-time PCR. Our results show that the bone marrow-derived Lin¯ cell population
demonstrates the properties to stimulate the skin tissue regeneration. Significant accelerated wound closure was revealed after cell
transplantation (P < 0.05). Histological analysis indicated the earliest inhibition of inflammation, accelerated reepithelialization, and
evenly distributed skin appendages in the neodermis after Lin¯ cell transplantation with type I collagen gel. The significant changes in
mRNA levels of cytokines TNF-α, IL-10, TGF-β, and VEGF after Lin¯ cell transplantation were confirmed by RT-PCR (P < 0.05). The
ability to positively control the reactions taking place during the wound healing process gives the advantage to the bone marrow Lin¯
cell population to be used as a cell source for therapy.
Key words: Bone marrow cells, wound healing, cytokine gene expression

1. Introduction
The skin loses its ability to self-repair following injuries that
penetrate deeper than the epidermis. Therefore, the healing
of full-thickness wounds mostly results in scar formation
and restoration of partially functional skin (Murawala
et al., 2012). Cell-based therapy is a promising strategy
for promoting tissue regeneration when conventional
treatments are not effective. The appropriate selection
of a cell source is one of the most important factors for
successful treatment (Arun et al., 2011). Adult stem cells
reside in many tissues of the postnatal organism and have
the potential to generate various mature cells. Skin wound
healing involves interactions between different cell types;
therefore, acceleration of regeneration process requires the
population of multifunctional cells (Ratajczak et al., 2004;
Kim and Suh, 2010; Bertozzi et al., 2017).
Bone marrow-derived lineage-negative (Lin¯) cells
form a heterogeneous population containing a variety
of cells at different level of differentiation including
hematopoietic stem cells (HSCs), mesenchymal stem cells
(MSCs), and endothelial progenitor cells (EPCs) (Wu et
al., 2007). These cells play multiple roles during various
stages of wound healing. In addition to their potential
* Correspondence: gene.biziuleviciene@imcentras.lt

to differentiate into cell types required for regeneration
of damaged tissue, stem cells can also produce various
cytokines critical for wound healing (Arno et al., 2011;
Lin et al., 2008). Exogenous bone marrow-derived stem
cells can decrease inflammation (Burd et al., 2007),
stimulate angiogenesis and reepithelialization (Zhang
and Fu, 2008; Yu et al., 2013), promote skin appendage
development (Arno et al., 2011), and prevent scar
formation (Srijaya et al., 2014). Although the progress
in stem cell research has been much improved, there
are still a number of problems that need to be resolved
before these cells can be widely used in clinical therapies
(Kim and Suh, 2010).
The choice of an accessible source to obtain a sufficient
cell amount and the use of suitable biomaterials to
improve the cell delivery efficiency are the main tasks
for safe, effective, and reliable application of stem cell
therapy (Burd et al., 2007). In this study, we investigated
the influence of bone marrow-derived Lin¯ cells on skin
regeneration in a BALB/c mice full-thickness wound
model. We examined the efficiency of wound healing after
local cell transplantation with or without injectable type I
collagen-based matrix.
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2. Materials and methods
2.1. Animals
Female BALB/c mice 8 weeks of age were used. Animals
were housed at 22 ± 2 °C under a 12-h light/dark cycle and
with free access to food and water. All procedures were
approved by the Lithuanian Ethics Committee on the Use
of Laboratory Animals under the State Veterinary Service.
2.2. Bone marrow cell isolation and lineage depletion
Bone marrow cells were isolated according to the method
described previously (Ramanauskaite et al., 2014).
Briefly, Lin¯ cells were isolated from femurs and tibiae
of BALB/c mice by flushing with sterile PBS using a
syringe needle (27-gauge). Collected cells were purified
using magnetic cell sorting techniques with the BD
IMag mouse hematopoietic progenitor enrichment set
(composed of BD IMag Streptavidin Particles Plus – DM
and biotin-conjugated monoclonal antibodies: antimouse
CD3e, clone 145-2C1; antimouse CD11b, clone M1/70;
antimouse CD45R/B220, clone RA3-6B2; antimouse Ly6G and Ly-6C (Gr-1), clone RB6-8C5; antimouse TER-119,
clone TER-119) (all from BD Biosciences, USA) applied as
recommended by the manufacturer. After purification,
cells were counted and examined for viability.
2.3. Phenotypic characterization of purified cells
Bone marrow lineage-depleted cells were analyzed by
flow cytometry. The following monoclonal antibodies
were used: phycoerythrin (PE)-labeled antimouse Sca1, allophycocyanin (APC)-labeled antimouse CD29,
PE-labeled antimouse CD90 (all from BD Biosciences),
fluorescein isothiocyanate (FITC)-labeled antimouse
CD117 (Miltenyi Biotec, Germany), and FITC-labeled
antimouse CD133 (Santa Cruz Biotechnology, USA).
Appropriate isotype matched controls were used as a
negative control. The cells were incubated with appropriate
amounts of antibodies for 30 min at 4 °C in the dark
and then analyzed by FACSCalibur flow cytometer (BD
Biosciences).
2.4. Skin wound model
Animals were anesthetized using a subcutaneous injection
of 0.5% bupivacaini hydrochloricum (0.05 mg/mouse).
Skin was shaved, cleaned, and disinfected with 70%
alcohol. A 6-mm punch biopsy tool was used to create a
full-thickness skin wound on the right side of the midline.
The animals were divided into four groups, 10 per group.
Group 1 received Lin¯ cells in PBS and group 2 received
Lin¯ cells in type I collagen (1.6 mg/mL) gel. Suspensions
of Lin¯ cells (1 × 106 cells in 50 µL of solution per mouse)
were injected intradermally around the wound at four
injection sites. Control groups 3 and 4 received PBS or
collagen gel without cells, respectively.
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2.5. Wound analysis
Digital photographs were taken on the day of surgery and
every day thereafter. Wound areas were measured every day,
and wound closure percentage was calculated as (wound
area/original wound area) × 100%. Mice were sacrificed
at various time points during healing. The wounded
tissues and the surrounding skin were excised with an
8-mm punch biopsy tool and bisected in the midline.
Half of the samples were fixed in 10% formalin solution
and embedded in paraffin. Microtomy was performed at
5 µm. Hematoxylin and eosin (H&E)-stained or Masson’s
trichrome-stained sections were used to determine quality
of the wound healing. The other half of the samples were
snap-frozen in liquid nitrogen and stored at –80 °C until
further processing.
2.6. Real-time PCR
Total RNA was isolated from frozen tissues using the
ISOLATE II RNA Mini Kit (Bioline, USA) according to
the manufacturer’s protocol. Isolated RNA was reversetranscribed with the High Capacity cDNA Reverse
Transcription Kit with RNase Inhibitor (Invitrogen,
USA) applied as recommended by the manufacturer.
Amplification of cDNA was performed using AmpliTaq
Gold Fast PCR Master Mix (Applied Biosystems, USA).
The sequences of the primers were as follows: β-actin
(f)
5’-TTCTACAATGAGCTGCGTGTGGC-3’,
(r)
5’-CTCATAGCTCTTCTCCAGGGAGGA-3’;
TGFβ1
(f)
5’-CGGGGCGACCTGGGCACCATCCATGAC-3’,
(r)
5’-CTGCTCCACCTTGGGCTTGCGACCCAC-3’;
VEGF (f) 5’-TGAACTTTCTGCTCTCTTGG-3’, (r)
5’-AACAAATGCTTTCTCCGCTC-3’;
TNF-α
(f)
5’-CAGCCTCTTCTCATTCCTGCTTGTG-3’,
(r)
5’-CTGGAAGACTCCTCCCAGGTATAT-3’;
IL-10
(f)
5’-CTGCTCTTACTGACTGGCATGAG-3’,
(r)
5’-GACTCAATACACACTGCAGGTGT-3’.
Results
were expressed as mRNA level in the wounds relative to
nonwounded skin. The relative levels of gene expression
were calculated by the reference to the β-actin in each
sample, using the cycle threshold (Ct) method.

2.7. Statistical analysis
All assays were repeated in at least three independent
experiments. Results were expressed as mean ± SD. Data
were analyzed by Student’s t-test. Results were considered
significant when P < 0.05.
3. Results

3.1. Phenotypic analysis of bone marrow-derived Lin¯
cells
The Lin¯ cell population was isolated from the total bone
marrow cell count by negative selection using magneticactivated cell sorting. Magnetic nanoparticles conjugated
with antibodies against differentiated cell surface markers
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were used. The results obtained showed that after
purification of the total bone marrow cell population,
3.5 ± 0.9% of cells remained in the negative fraction. To
test the purity of this cell population, the isolated Lin¯
cells were stained with monoclonal antibodies against the
differentiated cell surface markers and further analyzed
by flow cytometry. The results revealed that the presence
of surface markers in the purified cell population was less
than 2 ± 0.8%. To identify the undifferentiated cells in a
Lin¯ cell population, the following markers were selected:
CD117, Sca-1, CD90.1, CD29, and CD133. The expression
of CD117 was found to be the highest in the purified cell
population as up to 81.89 ± 2.92% of cells expressed this
marker. The expression of the remaining four markers in
the Lin¯ cell population was significantly lower. The Sca-1
molecule was expressed in 16.46 ± 3.51% cells, CD90 in
9.48 ± 2.93%, CD29 in 5.53 ± 1.8%, and CD133 in 6.64
± 0.93%. In comparison with the total bone marrow cell
population, the expression level of progenitor surface
markers in the Lin¯ cell population was up to 13-fold
higher (Table).
3.2. Effect of Lin¯ cells on wound closure
Wound closure was significantly different between control
and Lin¯ cell-treated groups over the observation period
(Figure 1). Among groups, where the injury was treated
with Lin¯ cells in PBS or type I collagen gel, there were
no significant differences in wound closure up to day 3.
Statistically significant changes in these groups were
registered only following day 4 after cell transplantation
and continuing until the end of the experiment. The
biggest difference in wound closure among the groups was
registered at day 10. In the group in which Lin¯ cells were
injected in combination with type I collagen gel, the open
wound area was 4.2 times smaller than that when the cells
were injected with PBS and 6.3 smaller as compared to
the control ones. Complete wound closure was detected
the earliest at day 12 after transplantation for Lin¯ cells
in type I collagen gel. In the group treated with Lin¯ cells
suspended in PBS solution, the wound area remained

Figure 1. Effect of Lin¯ cells on wound closure. Significant
accelerated wound healing was revealed after bone marrowderived Lin¯ cell transplantation with PBS (line A) or with type
I collagen gel (line B). No closed wounds were noticed over the
observation period in control groups where wounds received
PBS (line C) or type I collagen gel (line D) without cells. The data
represent the means ± SD. P < 0.05 for cell-treated wounds vs.
controls; *P < 0.05 for wounds after cell injection with collagen
gel vs. wounds after cell injection with PBS.

uncovered by 8.08 ± 0.26%. Complete wound closure in
this group was registered at day 14.
3.3. Histological analysis
Histological observation showed the initial phase of
proliferation 3 days after Lin¯ cell transplantation. At
this time, the beginning of the reepithelialization process
in both cell-injected groups was noticed (Figures 2a
and 2b). After cell transplantation in PBS solution,
hyperproliferative epidermis was noticed on the wound
edges (Figure 2a). In the group in which the injured skin
was treated with Lin¯ cells transplanted in type I collagen
gel, the forming epidermis was found evenly distributed
on the closed wound’s surface (Figure 2b). In the control
groups at day 3 an extensive infiltration of inflammatory
cells in tissue sections was seen (Figure 2c). Masson’s
trichrome-stained sections showed regenerated skin tissue

Table. Percentage of mouse bone marrow cells and Lin¯ fraction cells bearing undifferentiated cell
surface markers.
Cell surface marker

Total bone marrow

Lin¯ cell population

CD117

9.11 ± 2.76

81.89 ± 2.92

Sca-1

1.29 ± 0.05

16.46 ± 3.51

CD90

3.83 ± 0.21

9.48 ± 2.93

CD29

0.63 ± 0.11

5.53 ± 1.8

CD133

0.68 ± 0.08

6.64 ± 0.93

Values are means ± SD (n = 6).
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Figure 2. Histologic examination of wound healing at day 3. Initial phase of proliferation was revealed after bone
marrow-derived Lin¯ cell transplantation with PBS (a) or with type I collagen gel (b). Weak inflammation and no evident
reepithelization were noticed in control groups (c). Slides were stained with H&E. Bar: 100 µm (left) and 50 µm (right). De:
Dermis; Ep: epidermis; Gr: granulation tissue; In: infiltration of inflammatory cells. Dashed arrows indicate wound area;
dashed circles indicate edge of neoepidermis.
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12 days after Lin¯ cells transplantation. In both groups, a
layer of epidermis equivalent to normal tissue was formed.
The distribution of separate structures and collagen fibers
was indicated in the peripheral part of the restored tissue
and near the epidermis after transplantation of Lin¯ cells
suspended in PBS solution (Figure 3a). Most abundant
mature collagen fibers and skin appendages, distributed
over nearly the entire neodermis, were noticed after cell
transplantation with type I collagen gel (Figure 3b). In
cell-untreated groups, at day 12 the granulation tissue
layer and wide undifferentiated epidermis defined a still
ongoing phase of proliferation (Figures 3c and 3d).
3.4. Cytokine gene expression after Lin¯ cell
transplantation
We examined the expression of cytokine genes in wound
healing using a real-time PCR technique. The quantitative

analysis showed that the levels of IL-10, TNF-α, TGF-β1,
and VEGF mRNAs after Lin¯ cell transplantation were
significantly changed. The gene expression of TNF-α and
IL-10 significantly differed in all groups until days 4 and 3,
respectively (Figures 4a and 4b). After cell transplantation
in type I collagen gel at day 2, the level of TNF-α mRNA
was 22 times decreased as compared with the control
groups and 5 times decreased as compared with the other
cell-treated group (Figure 4a). Up to day 4, the mRNA
expression of IL-10 in the wounded tissue after treatment
with the Lin¯ cell populations in type I collagen gel was
found to be twice increased in comparison with the cells
in the PBS-treated group and up to 13 times increased in
comparison with the control groups (Figure 4b). After Lin¯
cell transplantation the expression of TGF-β1 mRNA was
changed at day 3 and remained so until day 9 (Figure 4c).

Figure 3. Histologic examination of wound healing at day 12. Different distributions of skin appendages were revealed after bone
marrow-derived Lin¯ cell transplantation with PBS (a) or with type I collagen gel (b). Wide layer of undifferentiated epidermis and
granulation tissue define an ongoing phase of proliferation in control groups where wounds received PBS (c) or type I collagen gel (d)
without cells. Slides were stained with Masson’s trichrome. Bar: 50 µm. De: Dermis; Ep: epidermis. Dashed lines indicate wound edge;
arrowheads indicate skin appendages.
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Figure 4. Cytokine gene expression during wound healing. Lin¯ cells influence mRNA levels of TNF-α (a), IL-10 (b), TGF-β (c), and
VEGF (d) in the healing process. Results are demonstrated as mRNA in the wounds relative to nonwounded skin. The relative levels
of gene expression were calculated by reference to β-actin in each sample using the cycle threshold (Ct) method and were expressed as
arbitrary units. The data represent means ± SD. *P < 0.05 for cell-treated wounds vs. controls; #P < 0.05 for wounds after cell injection
with collagen gel vs. wounds after cell injection with PBS.

In comparison with the results from the control group, the
expression of the TGF-β1 gene after cell transplantation
was found to be 1.5 and 5.9 times increased at days 9
and 3, respectively. Among the groups, where Lin¯ cells
were transplanted with or without type I collagen gel,
no significant changes were registered (Figure 4c). The
expression of the VEGF gene was significantly changed at
day 1 and remained so until day 7 after cell transplantation
(Figure 4d). After cell transplantation in type I collagen
gel, a significant difference (1.7 times) in VEGF mRNA
level was registered at day 3 as compared with the results
obtained from Lin¯ cells in the PBS solution-treated group.
The relative expression of this cytokine gene found after
cell transplantation was from two times greater at day 5 to
1.7 times greater at day 7 than in the cell-untreated groups
(Figure 4d).
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4. Discussion
In the present study the influence of bone marrowderived Lin¯ cells on wound healing was examined in vivo
using a BALB/c mice full-thickness skin wound model.
Wound macroscopic analysis and qualitative histological
examination were carried out. In addition, quantitative
changes in the gene expression of cytokines at the skin
injury site were tested.
The success of regenerative medicine depends on the
type and availability of therapeutically active cells, the
method of their delivery, and levels of engraftment after
transplantation (Ramanauskaite et al., 2010; Qing, 2017).
Heterogeneous bone marrow-derived Lin¯ cell populations
are attractive choice for cytotherapy. They contain multiple
types of undifferentiated cells with therapeutic potential
(Kim and Suh, 2010; Lee et al., 2016). As there is no one
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unique surface marker that could define specific stem or
progenitor cells, we used the combination of antibodies
against surface markers to evaluate types of primitive
cells in the Lin¯ population. The highest expression
of CD117 marker indicates that most of the cells in the
purified population are hematopoietic progenitors. The
expression of surface markers Sca-1, CD90, CD29, and
CD133 in the Lin¯ population was significantly lower. This
shows the necessity of cell expansion in vitro in order to
obtain required amounts of mesenchymal or endothelial
progenitors for transplantation. The use of Lin¯ cells is
advantageous because it allows us to obtain multiple types
of stem and progenitor cells, which interact and support
each other’s functions. Multifunctional properties of this
population could also be very useful to improve complex
wound healing process (Badiavas et al., 2003).
The present study compares wound healing after
bone marrow-derived Lin¯ cell transplantation with and
without injectable type I collagen-based gel. Macroscopic
examination showed a significant decrease of the wound
area within the first days in both cell-treated groups
as compared with the control groups. However, after
transplantation of Lin¯ cell with PBS or with collagen
gel, wound closure was not significantly different until
day 4. These results indicate that type I collagen did not
affect early reactions of macroscopic wound healing
but promoted cell integration into the wound area after
transplantation. Significant changes in wound reduction
among Lin¯ cell-treated groups were observed at day 4
and continued until the end of the experiment. Different
studies reported controversial results about the role of
various undifferentiated cell types in wound healing.
Rustad et al. reported accelerated wound closure after
treatment with MSC-seeded scaffolds at all time points
of healing but no long-term improvement of healing rate
when cells were transplanted without scaffolds (Rustad
et al., 2012). There are data in the literature stating that
stem cells could influence the restoration of functional
skin only after transplantation with the appropriate
biomaterials (Huang et al., 2012; Li et al., 2013) or after
additional genetic manipulations prior to transplantation
(Baraniak and McDevitt, 2013). In our study improved
wound healing was detected in both Lin¯ cell-treated
groups at all time points compared to the control groups.
These results suggest that multiple cell types interacting in
a Lin¯ population may enhance each other’s engraftment
after transplantation and increase their functionality
at the wound site. Nevertheless, the architecture of the
newly formed tissue was closest to the native skin after
cell transplantation in type I collagen gel. This shows that
support materials in cell transplantation may regulate
their distribution in the wound area and influence the
arrangement of regenerated appendages. Although the
mechanism of stem cell action is not completely clear,

histological findings in our study could be determined by
indirect activity of transplanted cells.
We have examined the gene expression of
proinflammatory TNF-α and antiinflammatory IL10. In addition, we have evaluated mRNA levels of
pleiotropic cytokine TGF-β1 and cytokine VEGF
involved in different phases of wound healing. Stem cells
can secrete several factors controlling the interaction
of the microenvironmental molecules and tissue cells,
influencing the proliferation and migration of the cells
participating in the tissue regeneration process (Anthony
and Shiels, 2013). They can also participate in the
inflammation and organization of the extracellular matrix
as well as stimulate the process of angiogenesis (Pedroso et
al., 2011; Grote et al., 2013; Yu et al., 2013). We found that
levels of TNF-α and IL-10 mRNAs in injured tissue were
significant different between the Lin¯ cell-treated groups.
Cell transplantation with type I collagen gel decreased the
expression of the cytokine TNF-α gene during 4 days by
5-fold as compared to wounds treated with cells without
gel. Levels of cytokine IL-10 mRNA gradually increased in
both cell-treated groups but after cell transplantation with
collagen I gel they were significant higher. This suggests
that Lin¯ cell transplantation with suitable material could
improve the integration into the wound area and lead to
early activity in healing reactions. Possible paracrine action
of various stem cell populations was shown in different
studies but results are still contradictory. Pedroso et al.
described a significant decrease in TNF-α levels in injured
skin after HSC transplantation but no marked influence on
IL-10 secretion was detected (Pedroso et al., 2011). There
is evidence that an inflammatory microenvironment also
improves the regenerative potential of bone marrow MSC
through induction of paracrine factors secretion, including
VEGF (Barrientos et al., 2008) and TGF-β (Liu et al., 2012).
Both cytokines are important in wound healing because
they promote angiogenesis and reepithelialization and can
prevent the formation of scars (Barrientos et al., 2008).
Our results indicated that the level of TGF-β1 mRNA
increases after Lin¯ cell transplantation at the end of the
inflammatory phase and remains so until the late phase of
proliferation. Differences were significant when compared
to the controls but not between cell-treated groups. The
expression of VEGF mRNA at the wound site after Lin¯ cell
administration was higher from the early inflammatory
phase until partway through the proliferation phase.
Changes were significant at all time points in comparison
with controls but only at day 3 when comparing wounds
after transplantation of cells in PBS and in type I collagen
gel. During the development of the proliferation phase,
the expression of VEGF mRNA in cell-treated groups was
found to be decreased but, nevertheless, it was higher than
that in the controls. Our findings show that bone marrow
Lin¯ cells affect the gene expression of cytokines important
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in multiple wound healing phases. Type I collagen gel
used for transplantation influences significant changes
of cytokine mRNA levels between cell-treated groups in
early healing reactions but not during the progress of the
later phases. Thus, we assume that collagen I may affect
the early paracrine effect of transplanted cells but does not
alter the long-term cytokine production.
In conclusion, the bone marrow Lin¯ cell
population possesses the properties to stimulate the

skin tissue regeneration. Our results show that after cell
transplantation the inhibition of inflammation occurs
earlier and the reepithelialization ends faster at the wound
site. In addition, transplanted Lin¯ cells significantly
change mRNA levels of cytokines important in multiple
wound healing phases. The ability to positively control the
reactions taking place during wound healing gives priority
to bone marrow Lin¯ cells to be used as a cell source for
therapy.
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